Zurich Insurance Group’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $146M | Sell |
337,778
-84,632
| -20% | -$25.7M | 1.02% | 18 |
|
|
2026
Q1 | $90.3M | Sell |
422,410
-344,011
| -45% | -$76.9M | 0.71% | 25 |
|
|
2025
Q4 | $131M | Buy |
766,421
+481,089
| +169% | +$74.8M | 0.91% | 20 |
|
|
2025
Q3 | $38.2M | Sell |
285,332
-837,100
| -75% | -$88.6M | 0.27% | 87 |
|
|
2025
Q2 | $109M | Buy |
1,122,432
+100,837
| +10% | +$8M | 0.84% | 38 |
|
|
2025
Q1 | $74.3M | Buy |
1,021,595
+595,943
| +140% | +$46.9M | 0.6% | 51 |
|
|
2024
Q4 | $30.7M | Buy |
+425,652
| New | +$32.3M | 0.25% | 105 |
|
|
2024
Q3 | – | Sell |
-905,000
| Closed | -$96.4M | – | 236 |
|
|
2024
Q2 | $96.4M | Buy |
905,000
+114,520
| +14% | +$11M | 0.84% | 31 |
|
|
2024
Q1 | $76.8M | Buy |
790,480
+748,480
| +1,782% | +$65.8M | 0.7% | 48 |
|
|
2023
Q4 | $3.29M | Hold |
42,000
| – | – | 0.03% | 143 |
|
|
2023
Q3 | $2.63M | Hold |
42,000
| – | – | 0.03% | 146 |
|
|
2023
Q2 | $2.7M | Hold |
42,000
| – | – | 0.03% | 132 |
|
|
2023
Q1 | $2.23M | Hold |
42,000
| – | – | 0.03% | 139 |
|
|
2022
Q4 | $1.77M | Hold |
42,000
| – | – | 0.03% | 130 |
|
|
2022
Q3 | $1.54M | Hold |
42,000
| – | – | 0.02% | 137 |
|
|
2022
Q2 | $1.79M | Hold |
42,000
| – | – | 0.03% | 140 |
|
|
2022
Q1 | $2.26M | Hold |
42,000
| – | – | 0.03% | 121 |
|
|
2021
Q4 | $3.02M | Hold |
42,000
| – | – | 0.03% | 106 |
|
|
2021
Q3 | $2.39M | Hold |
42,000
| – | – | 0.03% | 113 |
|
|
2021
Q2 | $2.73M | Hold |
42,000
| – | – | 0.03% | 108 |
|
|
2021
Q1 | $2.5M | Hold |
42,000
| – | – | 0.04% | 96 |
|
|
2020
Q4 | $1.98M | Buy |
+42,000
| New | +$1.77M | 0.03% | 109 |
|
|
2018
Q2 | – | Sell |
-36,280
| Closed | -$737K | – | 507 |
|
|
2018
Q1 | $737K | Sell |
36,280
-166,920
| -82% | -$3.31M | 0.02% | 487 |
|
|
2017
Q4 | $3.74M | Sell |
203,200
-49,370
| -20% | -$970K | 0.09% | 278 |
|
|
2017
Q3 | $4.67M | Buy |
252,570
+79,250
| +46% | +$1.29M | 0.13% | 195 |
|
|
2017
Q2 | $2.45M | Sell |
173,320
-44,440
| -20% | -$652K | 0.07% | 335 |
|
|
2017
Q1 | $2.79M | Sell |
217,760
-197,140
| -48% | -$2.32M | 0.08% | 288 |
|
|
2016
Q4 | $4.39M | Buy |
414,900
+72,750
| +21% | +$739K | 0.14% | 194 |
|
|
2016
Q3 | $3.24M | Buy |
+342,150
| New | +$3.11M | 0.11% | 225 |
|
Other funds holding LRCX
Zurich Insurance Group's LRCX Position: Q2 2026 in Review
Zurich Insurance Group reduced its Lam Research (LRCX) stake by 20% in Q2 2026, selling an estimated $25.7M and leaving 337,778 shares worth $146M. The position accounts for 1.02% of the portfolio, ranked #18.
Zurich Insurance Group first reported a position in LRCX in Q3 2016 and has held it in 29 quarters since. 3,125 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Zurich Insurance Group held 337,778 shares of Lam Research worth $146M as of Q2 2026.
- Zurich Insurance Group sold 84,632 Lam Research shares in Q2 2026, an estimated $25.7M.
- Lam Research made up 1.02% of Zurich Insurance Group's portfolio in Q2 2026, its #18 holding.
- Zurich Insurance Group first reported a position in Lam Research in Q3 2016 and has held it in 29 quarters since.
- 3,125 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.